216 related articles for article (PubMed ID: 31958463)
1. Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.
Haywood ME; Cocciolo A; Porter KF; Dobrinskikh E; Slavov D; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
J Mol Cell Cardiol; 2020 Feb; 139():124-134. PubMed ID: 31958463
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
[TBL] [Abstract][Full Text] [Related]
4. Determinants of ventricular arrhythmias in human explanted hearts with dilated cardiomyopathy.
Parajuli N; Valtuille L; Basu R; Famulski KS; Halloran PF; Sergi C; Oudit GY
Eur J Clin Invest; 2015 Dec; 45(12):1286-96. PubMed ID: 26444674
[TBL] [Abstract][Full Text] [Related]
5. Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.
Gigli M; Merlo M; Graw SL; Barbati G; Rowland TJ; Slavov DB; Stolfo D; Haywood ME; Dal Ferro M; Altinier A; Ramani F; Brun F; Cocciolo A; Puggia I; Morea G; McKenna WJ; La Rosa FG; Taylor MRG; Sinagra G; Mestroni L
J Am Coll Cardiol; 2019 Sep; 74(11):1480-1490. PubMed ID: 31514951
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients With Idiopathic Dilated Cardiomyopathy.
Verdonschot JAJ; Merken JJ; van Stipdonk AMW; Pliger P; Derks KWJ; Wang P; Henkens MTHM; van Paassen P; Abdul Hamid MA; van Empel VPM; Knackstedt C; Luermans JGLM; Crijns HJGM; Brunner-La Rocca HP; Brunner HG; Poelzl G; Vernooy K; Heymans SRB; Hazebroek MR
Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008727. PubMed ID: 32997547
[TBL] [Abstract][Full Text] [Related]
7. Genetic arrhythmias complicating patients with dilated cardiomyopathy.
Li Z; Chen P; Li C; Tan L; Xu J; Wang H; Sun Y; Wang Y; Zhao C; Link MS; Wilde AAM; Wang DW; Wang DW
Heart Rhythm; 2020 Feb; 17(2):305-312. PubMed ID: 31521807
[TBL] [Abstract][Full Text] [Related]
8. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease.
Kimura Y; de Riva M; Ebert M; Glashan C; Wijnmaalen AP; Piers SR; Dekkers OM; Trines SA; Zeppenfeld K
Circ Arrhythm Electrophysiol; 2023 Jan; 16(1):e010826. PubMed ID: 36595629
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
[TBL] [Abstract][Full Text] [Related]
11. Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype.
Massare J; Berry JM; Luo X; Rob F; Johnstone JL; Shelton JM; Bassel-Duby R; Hill JA; Naseem RH
J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1031-7. PubMed ID: 20233273
[TBL] [Abstract][Full Text] [Related]
12. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.
Assomull RG; Prasad SK; Lyne J; Smith G; Burman ED; Khan M; Sheppard MN; Poole-Wilson PA; Pennell DJ
J Am Coll Cardiol; 2006 Nov; 48(10):1977-85. PubMed ID: 17112987
[TBL] [Abstract][Full Text] [Related]
14. Myocardial transcriptome analysis of human arrhythmogenic right ventricular cardiomyopathy.
Gaertner A; Schwientek P; Ellinghaus P; Summer H; Golz S; Kassner A; Schulz U; Gummert J; Milting H
Physiol Genomics; 2012 Jan; 44(1):99-109. PubMed ID: 22085907
[TBL] [Abstract][Full Text] [Related]
15. Multiomics Analysis of Transcriptome, Epigenome, and Genome Uncovers Putative Mechanisms for Dilated Cardiomyopathy.
Liu L; Huang J; Liu Y; Pan X; Li Z; Zhou L; Lai T; Chen C; Wei B; Mo J; Wei Q; Yan W; Huang X; Zhang Z; Zhang Z; Huang M; He F; Huang Z
Biomed Res Int; 2021; 2021():6653802. PubMed ID: 33860048
[TBL] [Abstract][Full Text] [Related]
16. Silencing CTGF/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy.
Hong L; Lai HL; Fang Y; Tao Y; Qiu Y
J Cell Biochem; 2018 Nov; 119(11):9519-9531. PubMed ID: 30129221
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia.
Kitamura H; Ohnishi Y; Yoshida A; Okajima K; Azumi H; Ishida A; Galeano EJ; Kubo S; Hayashi Y; Itoh H; Yokoyama M
J Cardiovasc Electrophysiol; 2002 Sep; 13(9):865-70. PubMed ID: 12380923
[TBL] [Abstract][Full Text] [Related]
18. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
20. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
Cheedipudi SM; Matkovich SJ; Coarfa C; Hu X; Robertson MJ; Sweet M; Taylor M; Mestroni L; Cleveland J; Willerson JT; Gurha P; Marian AJ
Circ Res; 2019 Apr; 124(8):1198-1213. PubMed ID: 30739589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
